MSL 医学联络官- 肿瘤
职位描述
Medical & Scientific leadership for internal stakeholdersTo establish AstraZeneca as a scientific leader through proactive, updated and effective Medical inputDevelop and implement the local medical plan to address unmet medical needs in priority disease areas and ensure alignment with the brand plan. Provide medical input for the development of company’s Brand plans Provide the AZ internal stakeholders with an understanding of the local medical community, clinical practice, trends and real or perceived gaps in current scientific knowledge and medical treatment, competitive intelligence Develop and implement pre-launch medical plan/activities for new products at least 2 years prior to the planned launch in the country to address key clinical and scientific challengesProvide medical leadership on faculty and content development for medical programmes including national congresses, advisory boards, scientific exchange meetings, publications, CMEs to meet identified needsProvide medical input to global protocols, study feasibility and local customer’s research initiatives.Quantity% of trainings conducted versus planQualityFeedback from participantsFeedback from business partners on quality of contribution to Medical and Brand plans –collected by line managerFeedback on congress report/highlights shared with cross-functional team as planned – completed feedback templatesProvide medical input into the Life Cycle Management of priority brands and TAs to meet unmet medical needsParticipate as key member of brand team as strategic partner towards LCM actions Develop NIS or registry studies to address unmet medical needs Initiate discussions with customers to develop studies that will fulfill global and local business strategies. ESR Proposals- NumberFor NIS number of sites, KEEs, investigators involved in studies versus planTimely publications of studies completedGovernance and ensuring overall adherence to processes and regulationProvide medical input to the creation, development and agreement of promotional material and ensure all material is in line with internal SOPs and meets IFPMA code Support Clinical team to select appropriate investigators and sites optimising quality, delivery and commercial benefit Ensures compliance with AZ code of conduct, Corporate Governance, Audits requirement, guidelines, codes, policies and procedures Ensures that company confidentiality is maintained (i.e. intellectual property, product, strategic and salary information) Discloses potential breach of codes or conductsDisplay behaviours consistent with the AZ vision and values (those with line report, their team members demonstrates the same)Feedback from othersNo valid complaints from competitors against marketing practiceNo breach of confidentiality. All disclosureExternal Medical & Scientific engagementBuild, enhance and maintain the engagement with key external expertise (KEE). Proactively identify HCPs with high levels of scientific expertise in local treatment practice to collaborate on specific medical marketing activities Development and implementation of KEE engagement plan in collaboration with line manager. Develop database of KEEs and also provide recommendations for advisory board participation, potential speakers and train speakers as appropriate. Develop own scientific knowledge and share emerging data with HCPs, discussing all aspects of the data in a scientific, objective and balanced way. Disseminate results of studies completed to medical community by translating their clinical values and incorporating into business strategies. Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner.QuantityCoverage of KEEs versus planNo of Advisory Board Meetings versus planNo of P2Ps/round table discussions versus planNo of CMEs versus planImprovement in advocacy score as reviewed by line manager1:1QualityMeeting skills and presentation skills based on in field coaching and annual assessment – use standard assessment formPositive customer feedback post eventsDevelop or initiate scientific programs to explore unmet medical needs in priority disease area(s)Discuss potential involvement in ESR and RWEs. Interact in the field with KEEs for clinical trials, ESRs Able to conduct discussions on clinical trials in terms of study design and feasibilityQuantityNo of study communicatedQualityCustomer feedbackIn field observation by line managerDevelopmentContinuously demonstrate development of scientific expertise in disease area(s) of company focusPositive engagement and response to coaching and feedback received from line manager. In daily work takes time to reflect on customer interactions and works on areas agreed with line manager as priorities for development. Develop behaviours lead to enhanced effectiveness as outlined in Competency definitions. Proactively demonstrate the AZ Values Active participation in AZ training, projects, and meetings depending on development needsQuality100% completion of training as required on Medical AcademyAssessment of knowledge on coaching visits and assessmentHas a personal development plan and completes identified development activities as plannedComplianceCompliance with relevant company and industry code of Conduct and also to comply with local country codesKeep regular update and operate within the relevant Codes of Conduct, Ethical Interactions (EI), including GPEI and SOPs Be sure to understand AZ policies when engage to KEEs and external stakeholders100% adherence to compliance
企业简介
阿斯利康是全球领先制药公司,由前瑞典阿斯特拉公司和前英国捷利康公司于1999年合并而成。阿斯利康在6大治疗领域为患者提供富于创新,卓有成效的医药产品,包括消化、心血管、肿瘤、中枢神经、麻醉和呼吸等,其中许多产品居于世界领先地位。
阿斯利康总部位于英国伦敦,研发总部位于瑞典。产品销售覆盖全球100多个国家和地区。2005年公司销售收入为240亿美元。
阿斯利康拥有强大的研发能力,平均每个工作日的研发投入达到1400万美元 (2005年研发总投入为34亿美元)。我们在7个国家设有11个研发机构,共有11,900名员工从事与新药研发相关的工作。
阿斯利康拥有极具希望的早期开发产品组合,共有45个项目处于临床前研究阶段、17个项目处于一期临床研究阶段、13个项目处于二期临床研究阶段、6个项目处于三期临床研究阶段。
阿斯利康在全球19个国家有27个生产基地,共有14,000名员工致力于为客户提供安全、有效、高质量的产品。
阿斯利康在全球共有65,000名员工,从事医药产品和医疗服务的研发、生产和销售业务。
阿斯利康被列入道琼斯可持续发展指数(全球)以及显示企业良好社会责任度的富时社会责任指数(FTSE4Good Index)。
职位发布企业

该企业其他职位更多>>
- 面议 Translational Medicine Operation Asso. Manager
- 面议 医药代表(达州市宣汉+大足)
- 面议 医药代表
- 面议 医药代表(常德)
- 面议 医药代表(淮南)
- 面议 医药代表(邢台)
- 面议 医学代表-肺癌产品-江苏
- 面议 医学代表-肺癌产品-山东
- 面议 医学代表-肺癌产品-山东
- 面议 医学代表-肺癌产品-山东
相关职位推荐
贵州相关职位: KA代表(贵阳) 医药代表(血液) 医药销售代表(呼吸、儿科) 主管-贵州六盘水、毕节、黔西南 学术推广专员-贵阳 学术推广专员-六盘水 医药代表(贵阳贝伐) 医药代表(贵阳艾托组合抗体) 医药代表(贵阳-奥拉帕利) 医药代表(血液贵阳-罗普司亭、艾曲泊帕)
热门区域招聘: 重庆 北京 上海 浙江 江苏 广东 山东 湖南 安徽 河北
贵州招聘企业: 贵州益佰制药股份有限公司 贵州益佰制药股份有限公司 贵州益佰制药股份有限公司 贵州金佑康保健品有限公司 神奇药业事业部 贵州富华药品销售有限公司 圣济堂制药 贵州一致药业有限公司 贵州汇正制药有限责任公司 贵州省行销通贸易有限公司
职位发布日期: 2025-03-31